DD114414A5 - - Google Patents

Info

Publication number
DD114414A5
DD114414A5 DD182164A DD18216474A DD114414A5 DD 114414 A5 DD114414 A5 DD 114414A5 DD 182164 A DD182164 A DD 182164A DD 18216474 A DD18216474 A DD 18216474A DD 114414 A5 DD114414 A5 DD 114414A5
Authority
DD
German Democratic Republic
Application number
DD182164A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD114414A5 publication Critical patent/DD114414A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DD182164A 1973-11-07 1974-11-05 DD114414A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732355536 DE2355536A1 (de) 1973-11-07 1973-11-07 Adeninderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD114414A5 true DD114414A5 (en:Method) 1975-08-05

Family

ID=5897376

Family Applications (1)

Application Number Title Priority Date Filing Date
DD182164A DD114414A5 (en:Method) 1973-11-07 1974-11-05

Country Status (12)

Country Link
US (1) US3989833A (en:Method)
JP (1) JPS5077395A (en:Method)
BE (1) BE821893A (en:Method)
DD (1) DD114414A5 (en:Method)
DE (1) DE2355536A1 (en:Method)
DK (1) DK133810C (en:Method)
FR (1) FR2249672B1 (en:Method)
GB (1) GB1444690A (en:Method)
IL (1) IL45489A0 (en:Method)
NL (1) NL7414527A (en:Method)
SE (1) SE7413858L (en:Method)
ZA (1) ZA745309B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
AU626983B2 (en) * 1989-01-31 1992-08-13 Whitby Research, Inc. N6-substituted 9-methyladenines
US5670501A (en) * 1994-09-01 1997-09-23 Discovery Therapeutics, Inc. N-substituted 9-alkyladenines
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7203984A (en:Method) * 1971-04-10 1972-10-12

Also Published As

Publication number Publication date
DK133810C (da) 1976-12-13
IL45489A0 (en) 1974-11-29
DK580074A (en:Method) 1975-07-07
JPS5077395A (en:Method) 1975-06-24
AU7502574A (en) 1976-05-06
FR2249672B1 (en:Method) 1977-07-08
NL7414527A (nl) 1975-05-12
GB1444690A (en) 1976-08-04
DK133810B (da) 1976-07-26
US3989833A (en) 1976-11-02
FR2249672A1 (en:Method) 1975-05-30
SE7413858L (en:Method) 1975-05-09
DE2355536A1 (de) 1975-05-22
ZA745309B (en) 1975-09-24
BE821893A (fr) 1975-05-06

Similar Documents

Publication Publication Date Title
AR201758A1 (en:Method)
AU465372B2 (en:Method)
AR201235Q (en:Method)
AR201231Q (en:Method)
AU471343B2 (en:Method)
AU465453B2 (en:Method)
AU465434B2 (en:Method)
AU450229B2 (en:Method)
AR201229Q (en:Method)
AU466283B2 (en:Method)
AR199451A1 (en:Method)
FR2249672B1 (en:Method)
AU447540B2 (en:Method)
AR195948A1 (en:Method)
AR196382A1 (en:Method)
AR197627A1 (en:Method)
AR193950A1 (en:Method)
AR195311A1 (en:Method)
AR201432A1 (en:Method)
AU461342B2 (en:Method)
AR200885A1 (en:Method)
AR210729A1 (en:Method)
AR200256A1 (en:Method)
AU471461B2 (en:Method)
AR196212Q (en:Method)